Document is current

Article History

Received: 30 March 2025

Accepted: 25 June 2025

First Online: 19 August 2025

Declarations

:

: The study protocol, any amendments, the informed consent and other information that required pre-approval was reviewed by an Independent Ethics Committee, Bellberry Limited (Approval number 2023-11-1427). As the study involved anonymised structured data, which according to applicable legal requirements do not contain data subject to privacy laws, obtaining informed consent from patients by the investigators was not possible. This study adhered to the principles in accordance with the National Statement []. This study was conducted in accordance with the International Conference on Harmonisation (ICH) guidelines and the ethical principles that have their origin in the Declaration of Helsinki that are consistent with Good Clinical Practices (GCP) and applicable regulatory requirements.

: Not applicable.

: NL reports she has received payments from Pfizer for educational meetings. JCR reports in the last 36 months he has received honoraria for educational presentations for Abbvie, Novartis and Viatris. He has served on medical advisory boards for Pfizer, Viatris and Lilly. His institution has received funding for research grants, clinical trials and projects supported by the International Headache Society, Brain Foundation, Lundbeck, Abbvie, Pfizer and Aeon. AC and CST are employees of Telstra Health. BH, GS and DW are employees of Pfizer Australia.